Sanofi SA - ESG Rating & Company Profile powered by AI
Check the bottom of this page for potential risks for Sanofi SA based on sector, geography and size. Other companies in the rating peer group for Sanofi SA are shown. This SDG rating for Sanofi SA indicates the company's transparency towards the UN Sustainable Development Goals.
Sanofi SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Sanofi SA | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sanofi SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sanofi SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Sanofi SA report the average age of the workforce?
Sign up for free to unlockDoes Sanofi SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sanofi SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sanofi SA disclose cybersecurity risks?
Sign up for free to unlockDoes Sanofi SA offer flexible work?
Sign up for free to unlockDoes Sanofi SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sanofi SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sanofi SA conduct supply chain audits?
Sign up for free to unlockDoes Sanofi SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sanofi SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sanofi SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sanofi SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sanofi SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sanofi SA disclose water use targets?
Sign up for free to unlockDoes Sanofi SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Sanofi SA have a product recall in the last two years?
Sign up for free to unlockDoes Sanofi SA disclose incidents of discrimination?
Sign up for free to unlockDoes Sanofi SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sanofi SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sanofi SA disclose parental leave metrics?
Sign up for free to unlockDoes Sanofi SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sanofi SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sanofi SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sanofi SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sanofi SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sanofi SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sanofi SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Sanofi SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sanofi SA disclose its waste policy?
Sign up for free to unlockDoes Sanofi SA report according to TCFD requirements?
Sign up for free to unlockDoes Sanofi SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sanofi SA disclose energy use targets?
Sign up for free to unlockDoes Sanofi SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sanofi SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sanofi SA
These potential risks are based on the size, segment and geographies of the company.
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.